These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22058027)

  • 1. Targeted therapies in diabetic nephropathy: an update.
    Gupta A; Gupta P; Biyani M
    J Nephrol; 2011; 24(6):686-95. PubMed ID: 22058027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy.
    Cooper ME
    Diabetologia; 2001 Nov; 44(11):1957-72. PubMed ID: 11719827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapeutic strategies in diabetic nephropathy.
    Ravera M; Re M; Weiss U; Deferrari L; Deferrari G
    J Nephrol; 2007; 20 Suppl 12():S23-32. PubMed ID: 18050139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
    Navarro-González JF; Muros M; Mora-Fernández C; Herrera H; Meneses B; García J
    J Diabetes Complications; 2011; 25(5):314-9. PubMed ID: 21144773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?
    Coughlan MT; Cooper ME; Forbes JM
    Ann N Y Acad Sci; 2005 Jun; 1043():750-8. PubMed ID: 16037302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of oxidative stress in pathogenesis of diabetic nephropathy].
    Inoguchi T
    Nihon Jinzo Gakkai Shi; 2011; 53(7):1016-20. PubMed ID: 22073866
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of diabetic nephropathy--old buddies and newcomers part 2.
    Nawroth PP; Isermann B
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):667-72. PubMed ID: 20658437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapies of diabetic nephropathy.
    Burney BO; Kalaitzidis RG; Bakris GL
    Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):107-11. PubMed ID: 19434047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A; Majkowska L
    Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.
    Inagi R; Nangaku M; Miyata T
    Ann N Y Acad Sci; 2005 Jun; 1043():605-8. PubMed ID: 16037283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renin inhibition and the kidney].
    Ecder T
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK; Sodhi RK; Singh M
    Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of pathophysiology and management of diabetic kidney disease.
    Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
    J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and the pathogenesis of diabetic nephropathy.
    Wada J; Makino H
    Clin Sci (Lond); 2013 Feb; 124(3):139-52. PubMed ID: 23075333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.
    Feldman DL
    Hypertens Res; 2010 Apr; 33(4):279-87. PubMed ID: 20203685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
    Wolf G
    Eur J Clin Invest; 2004 Dec; 34(12):785-96. PubMed ID: 15606719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
    Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.